Takafumi Ikeda
- Cancer Research top 10%
- Breast Cancer Treatment Studies 5
- Bioengineering top 5%
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 4
-
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 3
- Spectroscopy top 10%
-
- Estrogen and related hormone effects 4
-
- Neurobiology and Insect Physiology Research 3
-
- Phytochemistry and Biological Activities 3
-
- Ovarian cancer diagnosis and treatment 3
- Co-authors
- Akira ShimizuMasakazu ToiTomoharu SugieC. Richard HutchinsonAtsushi KawaguchiKenichi YoshimuraNobuo IkekawaTakayuki Kinoshita
- Journals
- Journal of the American Chemical Society (1 paper)Journal of Clinical Oncology (3 papers)PLoS ONE (1 paper)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Takafumi Ikeda
41 papers receiving 900 citations
Peers
Comparison fields: 5 of 112
- Cancer Research 219
- Bioengineering 77
- Pathology and Forensic Medicine 182
- Oncology 173
- Spectroscopy 102
Countries citing papers authored by Takafumi Ikeda
This map shows the geographic impact of Takafumi Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takafumi Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takafumi Ikeda more than expected).
Fields of papers citing papers by Takafumi Ikeda
This network shows the impact of papers produced by Takafumi Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takafumi Ikeda. The network helps show where Takafumi Ikeda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takafumi Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 15 | |
| 10 | 2020 | 19 | |
| 11 | 2018 | 28 | |
| 12 | 2017 | 14 | |
| 13 | Transcutaneous oxygen pressure as a surrogate index of lower limb amputation. | 2016 | 13 |
| 14 | 2016 | 80 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 53 | |
| 17 | 2013 | 123 | |
| 18 | 2007 | 15 | |
| 19 | 1999 | 12 | |
| 20 | 1994 | 18 |
About Takafumi Ikeda
Takafumi Ikeda is a scholar working on Bioengineering, Reproductive Medicine and Cancer Research, having authored 45 papers that have together received 927 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Estrogen and related hormone effects (4 papers), Breast Lesions and Carcinomas (4 papers), Neurobiology and Insect Physiology Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Phytochemistry and Biological Activities (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (219 citations), Bioengineering (77 citations) and Pathology and Forensic Medicine (182 citations). Takafumi Ikeda has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Akira Shimizu, Masakazu Toi, Tomoharu Sugie, C. Richard Hutchinson, Atsushi Kawaguchi, Kenichi Yoshimura, Nobuo Ikekawa, Takayuki Kinoshita, Eiji Ohnishi and Terumasa Sawada. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.